"10.1371_journal.pone.0127244","plos one","2015-06-24T00:00:00Z","Yumi Shirai; Yuko Fujita; Ryota Hashimoto; Kazutaka Ohi; Hidenaga Yamamori; Yuka Yasuda; Tamaki Ishima; Hiroyuki Suganuma; Yusuke Ushida; Masatoshi Takeda; Kenji Hashimoto","Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan; Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan; Research & Development Division, Kagome Co. Ltd., Tochigi, Japan","Conceived and designed the experiments: KH. Performed the experiments: YS YF RH KO HY YY TI. Analyzed the data: YS RH KO. Contributed reagents/materials/analysis tools: KO HY YY HS YU MT. Wrote the paper: YS RH KO KH.","The authors have the following interests: Drs. H. Suganuma and Y. Ushida are employees of Kagome Co, Ltd., which provided SFN-rich supplement. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.","2015","06","Yumi Shirai","YS",11,TRUE,1,7,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
